Annotated Medicine and Device Lists


Bisoprolol

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.1. Antianginal medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.2. Antiarrhythmic medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.4. Medicines used in heart failure Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 07 AGENTES BETA-BLOQUEANTES No observations
Guyana. Essential Medicines List. 2020-2021 Restricted Medicines No observations
Suriname. NGK-C-011 12.1 Agents for Angina Pectoris No observations
Suriname. NGK-C-011 12.2 Antiarrhythmic drugs No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Suriname. NGK-C-011 12.4 Medicines for Heart Failure No observations
Haiti. National List of Essential Medicines 12.01 Antianginals No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.24 Beta Adrenergic Blocking Agents No observations

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives No observations
Haiti. National List of Essential Medicines 12.04 Medicines for heart failure No observations

This medicine is present in:

List Section Observation
Barbados. Barbados National Drug Formulary (BNDF) 24.24 Beta Adrenergic Blocking Agents No observations

This medicine is present in:

List Section Observation
Suriname. NGK-C-011 12.1 Agents for Angina Pectoris No observations
Suriname. NGK-C-011 12.2 Antiarrhythmic drugs No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Suriname. NGK-C-011 12.4 Medicines for Heart Failure No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.24 Beta Adrenergic Blocking Agents No observations

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives No observations
Haiti. National List of Essential Medicines 12.04 Medicines for heart failure No observations

This medicine is present in:

List Section Observation
Peru 12.4 Medications Used in Cardiac Insufficiency No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.1. Antianginal medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.2. Antiarrhythmic medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.4. Medicines used in heart failure Others observations:
Includes metoprolol and carvedilol as alternatives.
This medicine has the best evidence for effectiveness and safety.
Suriname. NGK-C-011 12.1 Agents for Angina Pectoris No observations
Suriname. NGK-C-011 12.2 Antiarrhythmic drugs No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Suriname. NGK-C-011 12.4 Medicines for Heart Failure No observations
Haiti. National List of Essential Medicines 12.01 Antianginals No observations

Information Resources: Bisoprolol

Loading ...
Loading ...
Loading ...
No information available